Catalyst Pharmaceuticals Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$148,392	$146,563	$141,421	$141,820
Gross Profit	123,081	116,605	123,510	120,177
EBITDA	80,451	78,753	72,827	72,301
EBIT	71,035	69,293	63,367	62,843
Net Income	52,783	52,108	56,737	55,936
Net Change In Cash	148,392	146,563	141,421	141,820
Free Cash Flow	32,438	71,272	60,043	70,789
Cash	689,892	652,800	580,656	517,553
Basic Shares	127,090	127,543	126,958	126,280

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$491,734	$398,204	$214,203	$140,833
Gross Profit	422,889	346,237	179,810	118,949
EBITDA	232,898	119,693	103,077	52,577
EBIT	195,124	86,812	101,838	52,385
Net Income	163,889	71,410	83,079	39,482
Net Change In Cash	491,734	398,204	214,203	140,833
Cost of Revenue			126,950	41,208
Free Cash Flow	239,252	61,856	116,018	59,351
Cash	517,553	137,636	298,395	171,445
Basic Shares	124,944	113,753	111,375	107,795